Fadini, Gian Bonora, Benedetta Zatti, Giancarlo Vitturi, Nicola Iori, Elisabetta Marescotti, Maria Albiero, Mattia Avogaro, Angelo MOESM1 of Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial Additional file 1. Supplemental data on cholesterol efflux capacity and bioimpedance vector analysis. Atherosclerosis;Body composition;Therapy 2017-04-04
    https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Effects_of_the_SGLT2_inhibitor_dapagliflozin_on_HDL_cholesterol_particle_size_and_cholesterol_efflux_capacity_in_patients_with_type_2_diabetes_a_randomized_placebo-controlled_trial/4817356
10.6084/m9.figshare.c.3734152_D1.v1